References
Liu, Y, Wang HY, Shao J, Zaro J, Shen, WC. (2020) Enhanced insulin receptor interaction by a bifunctional insulin-transferrin fusion protein: An approach to overcome insulin resistance. Sci Reports. 10: 7724 (PMID 32382087)
Chen YC, Zaro JL, Zhang D, Huang N, Simon A, Shen WC. (2018) Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed using ExpressTec. Int J Mol Sci. Vol 19: pg 378.
Shao J, Zaro JL, Shen WC. (2016) Proinsulin-Transferrin Fusion Protein Exhibits a Prolonged and Selective Effect on the Control of Hepatic Glucose Production in an Experimental Model of Type 1 Diabetes. Mol Pharm. 2016 Aug 1; Vol 13(8): pgs 2641-6 (PMID: 27280852).
Wang Y, Shao J, Zaro JL, Shen WC. (2014) Proinsulin-Transferrin Fusion Protein as a Novel Long-acting Insulin Analogue for the Inhibition of Hepatic Glucose Production. Diabetes 63(5): 1779-1788 (PMID 14353179).
Zhang D, Lee HF, Pettit SC, Zaro JL, Huang N, Shen WC. (2012) Characterization of transferrin receptor- mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.). BMC Biotechnol, 12:92 (PMID 23194296).
Wang Y, Chen YS, Zaro JL, Shen WC. (2011) Receptor-mediated activation of a proinsulin- transferrin fusion protein in hepatoma cells. J Control Release, 155(3): 386-392 (PMID 21756950).
Chen X, Lee HF, Zaro JL, Shen WC. (2011) Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins. Mol Pharm, 8(2): 457-465 (PMID 21291358).